(2013)
Hsp21 potentiates antifungal drug tolerance in Candida albicans.
PLOS One 8(3),
e60417.
Publikationen
(2013)
Candida albicans pathogenicity mechanisms.
Virulence 4(2),
119-128.
(Review)
(2013)
Thriving within the host: Candida spp. interactions with phagocytic cells.
Med Microbiol Immunol 202(3),
183-195.
(Review)
(2013)
Limitation of (1→3)-β-D-glucan monitoring in major elective surgery involving cardiopulmonary bypass.
Crit Care 17(3),
437.
(2013)
Global transcriptome sequencing identifies chlamydospore specific markers in Candida albicans and Candida dubliniensis.
PLOS One 8(4),
e61940.
(2013)
Secreted aspartic proteases of Candida albicans activate the NLRP3 inflammasome.
Eur J Immunol 43(3),
679-692.
(2013)
A peptide derived from the highly conserved protein GAPDH is involved in tissue protection by different antifungal strategies and epithelial immunomodulation.
J Invest Dermatol 133(1),
144-153.
(2013)
Clotrimazole dampens vaginal inflammation and neutrophil infiltration in response to Candida albicans infection.
Antimicrob Agents Chemother 57(10),
5178-5180.
(2012)
Complement plays a central role in Candida albicans-induced cytokine production by human PBMCs.
Eur J Immunol 42(4),
993-991004.
(2012)
Candida albicans scavenges host zinc via Pra1 during endothelial invasion.
PLOS Pathog 8(6),
e1002777.